Home > Qtrly Results > GLAND PHARMA

GLAND PHARMA
Quarterly Results Analysis [Mar2025]

GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Quarterly Results

Consolidated Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
UnAudited
Jun2023
UnAudited
Revenues ₹1,425 Cr ₹1,384 Cr ₹1,406 Cr ₹1,402 Cr ₹1,537 Cr ₹1,545 Cr ₹1,373 Cr ₹1,209 Cr
Expenses ₹1,077 Cr ₹1,024 Cr ₹1,109 Cr ₹1,137 Cr ₹1,179 Cr ₹1,189 Cr ₹1,049 Cr ₹915 Cr
Operating Income ₹348 Cr ₹360 Cr ₹297 Cr ₹264 Cr ₹359 Cr ₹356 Cr ₹324 Cr ₹294 Cr
Other Income ₹44 Cr ₹58 Cr ₹60 Cr ₹51 Cr ₹42 Cr ₹37 Cr ₹53 Cr ₹38 Cr
Interest ₹7 Cr ₹23 Cr ₹6 Cr ₹6 Cr ₹10 Cr ₹5 Cr ₹6 Cr ₹5 Cr
Depreciation ₹96 Cr ₹96 Cr ₹94 Cr ₹92 Cr ₹93 Cr ₹105 Cr ₹81 Cr ₹65 Cr
Profit Before Tax ₹288 Cr ₹299 Cr ₹257 Cr ₹218 Cr ₹298 Cr ₹283 Cr ₹290 Cr ₹261 Cr
Profit After Tax ₹187 Cr ₹205 Cr ₹164 Cr ₹144 Cr ₹192 Cr ₹192 Cr ₹194 Cr ₹194 Cr
EPS ₹11.32 ₹12.42 ₹9.93 ₹8.73 ₹11.68 ₹11.65 ₹11.78 ₹11.79
Industry Peers & Returns1W1M1Y
GLAND PHARMA 5.3% 16.5% 0.8%
SUN PHARMACEUTICAL INDUSTRIES -0.2% -0.5% 10.7%
DIVIS LABORATORIES 4% 4.8% 50.5%
CIPLA 0.4% 3.1% 1.6%
TORRENT PHARMACEUTICALS 5.9% 9.1% 23%
DR REDDYS LABORATORIES -4.8% 2.2% 2.9%
MANKIND PHARMA -0.9% -5.2% 8.7%
ZYDUS LIFESCIENCES 2.7% 7.8% -6.5%
LUPIN 1.4% 0.1% 22.3%

GLAND PHARMA Quarterly Revenues

Revenues
Q-o-Q

2.95 %

Y-o-Y

-7.32 %

Quarters Revenues % Change
Mar2025 ₹1,425 Cr
2.95
Dec2024 ₹1,384 Cr
-1.55
Sep2024 ₹1,406 Cr
0.29
Jun2024 ₹1,402 Cr
-8.83
Mar2024 ₹1,537 Cr
-0.50
Dec2023 ₹1,545 Cr
12.50
Sep2023 ₹1,373 Cr
13.63
Jun2023 ₹1,209 Cr -

GLAND PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

-3.46 %

Y-o-Y

-3.10 %

Quarters Operating Profit % Change
Mar2025 ₹348 Cr
-3.46
Dec2024 ₹360 Cr
21.17
Sep2024 ₹297 Cr
12.35
Jun2024 ₹264 Cr
-26.28
Mar2024 ₹359 Cr
0.63
Dec2023 ₹356 Cr
9.97
Sep2023 ₹324 Cr
10.25
Jun2023 ₹294 Cr -
Operating Margins
Q-o-Q

-6.23 %

Y-o-Y

4.54 %

Quarters Operating Margin% % Change
Mar2025 24.39%
-6.23
Dec2024 26.01%
23.10
Sep2024 21.13%
12.04
Jun2024 18.86%
-19.16
Mar2024 23.33%
1.17
Dec2023 23.06%
-2.29
Sep2023 23.6%
-2.96
Jun2023 24.32% -

GLAND PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

-8.87 %

Y-o-Y

-3.06 %

Quarters Profit After Tax % Change
Mar2025 ₹187 Cr
-8.87
Dec2024 ₹205 Cr
25.17
Sep2024 ₹164 Cr
13.75
Jun2024 ₹144 Cr
-25.29
Mar2024 ₹192 Cr
0.29
Dec2023 ₹192 Cr
-1.15
Sep2023 ₹194 Cr
-0.01
Jun2023 ₹194 Cr -
PAT Margins
Q-o-Q

-11.49 %

Y-o-Y

4.55 %

Quarters PAT Margin(%) % Change
Mar2025 13.09 %
-11.49
Dec2024 14.79 %
27.17
Sep2024 11.63 %
13.35
Jun2024 10.26 %
-18.05
Mar2024 12.52 %
0.81
Dec2023 12.42 %
-12.10
Sep2023 14.13 %
-12.02
Jun2023 16.06 % -

GLAND PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

-8.86 %

Y-o-Y

-3.08 %

Quarters EPS % Change
Mar2025 ₹11.32
-8.86
Dec2024 ₹12.42
25.08
Sep2024 ₹9.93
13.75
Jun2024 ₹8.73
-25.26
Mar2024 ₹11.68
0.26
Dec2023 ₹11.65
-1.10
Sep2023 ₹11.78
-0.08
Jun2023 ₹11.79 -

You may also like the below Video Courses